07 September 2021>: Articles
Acute Lower Extremity Arterial Thrombosis Associated with Osimertinib-Induced Erythrocytosis
Unusual or unexpected effect of treatment, Adverse events of drug therapy
Shota Kodaira A , Jun Ehara A* , Shigemasa Takamizawa A , Shin Ogita E , Yasuhiro Norisue E , Tatsuya Nakama E , Eiji Hiraoka ADOI: 10.12659/AJCR.932252
Am J Case Rep 2021; 22:e932252
Figure 1. The trend of hemoglobin (Hb) level. The trend of Hb level from the initiation of osimertinib therapy is shown. The arrow indicates the timepoint at which acute arterial thrombosis developed and osimertinib was discontinued.